You are here: Geisinger Medical
Laboratories > Test
Catalog
Geisinger Medical Laboratories/Geisinger Proven Diagnostics Test Catalog
HEPATITIS C ANTIBODY |
||
ORDERING INFORMATION: |
Geisinger Epic Procedure Code: LAB2442 Geisinger Epic ID: 17584 | |
SPECIMEN COLLECTION |
||
Specimen type: |
Serum. | |
Preferred collection container: |
||
Alternate Collection Container: |
Gold-top (serum separator) microcollection tube
6 mL red-top (plain, non-serum separator) tube
|
|
Specimen required: |
1 mL aliquot; minimum 0.5 mL. | |
| SPECIMEN PROCESSING |
||
Specimen processing instructions: |
Allow serum to clot. Centrifuge to separate serum within 2 hours of collection. | |
Transport temperature: |
Refrigerated. | |
Specimen stability: |
Room temperature: 3 days. Refrigerated: 21 days at 2-8°C. Frozen: 3 months. | |
Rejection criteria: |
Specimen will be rejected if stability limits have been exceeded or if specimen is hemolyzed, lipemic, or icteric. Add-ons available only to unopened tube. | |
TEST DETAILS |
||
Reference interval: |
Negative. | |
Additional information: |
Department of Health is notified for PA residents if positive. | |
CPT code(s): |
86803 | |
| Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Test includes: |
Qualitative detection of Immunoglobulin G antibodies to hepatitis C virus. | |
Methodology: |
Chemiluminescence Immunoassay |
|
Synonyms: |
Anti-HCV, HCV Total Antibody, HCVAB
|
|
Clinical significance: |
HCV assay is an in vitro diagnostic immunoassay for the qualitative determination of immunogluboulin G (IgG) antibodies to hepatitis C virus (HCV) in human serum. The presence of antibodies to HCV indicates that an individual may have been infected with HCV or may be capable of transmitting HCV infection. | |
Doctoral Director(s:) |
Hoi-Ying Elsie Yu, PhD, DABCC Sheng-Ying (Margaret) Lo, PhD, DABCC |
|
| Review Date: | 12/14/2022 | |